The menopause: benefits and risks of estrogen-progestogen replacement therapy.
D000328:Adult; D001284:Atrophy / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000378:metabolism; D001943:Breast Neoplasms / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002769:Cholelithiasis / Q000139:chemically induced; D002979:Climacteric / Q000187:drug effects; D004714:Endometrial Hyperplasia / Q000139:chemically induced; D004848:Epithelium / Q000473:pathology; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use*; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D014566:Urogenital System / Q000473:pathology; D014594:Uterine Neoplasms / Q000139:chemically induced
D001779:Blood Coagulation Factors; D004967:Estrogens; D008074:Lipoproteins; D011372:Progestins